SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (22764)12/16/2005 5:19:18 PM
From: epicure  Respond to of 78776
 
I like COP as well.

Nice move on PFE in the after hours market (was it you who bought it too?)-

Court rules Ranbaxy infringes Pfizer's Lipitor patents
Friday December 16, 5:06 pm ET

NEW YORK (Reuters) - A federal judge on Friday upheld the validity of two key U.S. patents on Pfizer Inc.'s (NYSE:PFE - News) Lipitor cholesterol drug, lending a setback to Indian drugmaker Ranbaxy Laboratories Ltd which had hoped to introduce a generic version of the medicine.

up 2.72 so far :-) Of course AH trading- who knows what it means? But I thought I would mention it for those of you who own PFE.